Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1336 CNY

100%

CVE-2026-31278

Quick assessment

Affected
supremainc BioStar 2
Exploitation
No confirmed in-the-wild exploitation; assess based on exposure
Recommended action
Check the vendor advisory and references for a fixed version. If immediate upgrade is impossible, restrict exposure and increase monitoring.

Suprema BioStar 2(版本低于 2.9.12)和 BioStar X(版本低于 1.0.2)的 端点存在一个问题,允许攻击者通过构造一个特定的 GET 请求,以明文形式获取活动目录(Active Directory)服务账户的凭据。

CVSS 7.7 · High

Possible ATT&CK Techniques 1 AI

T1003 · OS Credential Dumping
Get alerts for future matching vulnerabilities Log in to subscribe

I. Basic Information for CVE-2026-31278

Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: CVE Program / CVE List V5
Vulnerability Description
An issue in the /api/v2/setting/adserversetting endpoint of Suprema BioStar 2 before 2.9.12 and and BioStar X before 1.0.2 allows attackers to obtain Active Directory service account credentials in cleartext by supplying a crafted GET request.
Source: CVE Program / CVE List V5
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:N/A:N
Source: CVE Program / CVE List V5
Vulnerability Type
敏感数据的明文传输
Source: CVE Program / CVE List V5

Affected Products

Vendor Product Affected Versions CPE Subscribe
supremainc BioStar 2 0 ~ 2.9.12 -

II. Public POCs for CVE-2026-31278

# POC Description Source Link Shenlong Link
AI-Generated POC Premium

No public POC found.

Login to generate AI POC

III. Intelligence Information for CVE-2026-31278

登录查看更多情报信息。

Proof of Concept for CVE-2026-31278 (1)

Vendor Pages for CVE-2026-31278 (1)

IV. Related Vulnerabilities

V. Comments for CVE-2026-31278

No comments yet


Leave a comment